Clinical trials
5 active studies led by EyeBiotech Ltd., of 7 in all
Source: ClinicalTrials.gov, Studies with EyeBiotech Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show EyeBiotech Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by EyeBiotech Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
5 active studies led by EyeBiotech Ltd., of 7 in all
Source: ClinicalTrials.gov, Studies with EyeBiotech Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies EyeBiotech Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with EyeBiotech Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show EyeBiotech Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets EyeBiotech Ltd. is in.
Stories on the topics EyeBiotech Ltd. works in.
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Over 9.5 million people live with type 1 diabetes and need insulin every day. How delivery devices are…
Read